Cantabio Pharmaceuticals Inc (CTBO)
1.01
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Cantabio Pharmaceuticals Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.148M |
| May 02, 2024 | 1.148M |
| May 01, 2024 | 1.148M |
| April 30, 2024 | 1.148M |
| April 29, 2024 | 1.148M |
| April 26, 2024 | 1.148M |
| April 25, 2024 | 1.148M |
| April 24, 2024 | 1.148M |
| April 23, 2024 | 1.148M |
| April 22, 2024 | 1.148M |
| April 19, 2024 | 1.148M |
| April 18, 2024 | 1.148M |
| April 17, 2024 | 1.148M |
| April 16, 2024 | 1.148M |
| April 15, 2024 | 1.148M |
| April 12, 2024 | 1.148M |
| April 11, 2024 | 1.148M |
| April 10, 2024 | 1.148M |
| April 09, 2024 | 1.148M |
| April 08, 2024 | 1.148M |
| April 05, 2024 | 1.148M |
| April 04, 2024 | 1.148M |
| April 03, 2024 | 1.148M |
| April 02, 2024 | 1.148M |
| April 01, 2024 | 1.148M |
| Date | Value |
|---|---|
| March 28, 2024 | 1.148M |
| March 27, 2024 | 1.148M |
| March 26, 2024 | 1.148M |
| March 25, 2024 | 1.148M |
| March 22, 2024 | 1.148M |
| March 21, 2024 | 1.148M |
| March 20, 2024 | 1.148M |
| March 19, 2024 | 1.148M |
| March 18, 2024 | 1.148M |
| March 15, 2024 | 1.148M |
| March 14, 2024 | 1.148M |
| March 13, 2024 | 1.148M |
| March 12, 2024 | 1.148M |
| March 11, 2024 | 1.148M |
| March 08, 2024 | 1.148M |
| March 07, 2024 | 1.148M |
| March 06, 2024 | 1.148M |
| March 05, 2024 | 1.148M |
| March 04, 2024 | 1.148M |
| March 01, 2024 | 1.148M |
| February 29, 2024 | 1.148M |
| February 28, 2024 | 1.148M |
| February 27, 2024 | 1.148M |
| February 26, 2024 | 1.148M |
| February 23, 2024 | 1.148M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.148M
Minimum
Aug 19 2021
2.082M
Maximum
May 07 2019
1.399M
Average
1.148M
Median
Aug 19 2021
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.343M |
| Total Expenses (Quarterly) | 0.2402M |
| EPS Diluted (Quarterly) | 19.63 |